about
Role of nanotechnology and gene delivery systems in TRAIL-based therapiesThe Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell PhenotypePaclitaxel derivatives for targeted therapy of cancer: toward the development of smart taxanes.Further studies on the protein conjugation of hydroxamic acid bifunctional chelating agents: group-specific conjugation at two different loci.Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers.Recurrent read-through fusion transcripts in breast cancer.Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer.Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipinDCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapyMulti-targeted therapy of cancer by niclosamide: A new application for an old drug.Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancerThe C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells.Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells.S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.Thrombospondin-1 opens the paracellular pathway in pulmonary microvascular endothelia through EGFR/ErbB2 activation.CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinomaSurveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer.Gene expression imaging with radiolabeled peptides.Dynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse modelMolecular targeted approaches for treatment of pancreatic cancer.A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer.TRAIL receptor-targeted therapy.Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancers.SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer XenograftsBrief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.Immunohistochemistry in the evaluation of neovascularization in tumor xenograftsIn vivo efficacy of marimastat and chemoradiation in head and neck cancer xenograftsCatalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancersTherapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation.Monoclonal antibodies in the treatment of pancreatic cancer.Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model.Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.Effect of backscatter on cell survival for a clinical electron beam.Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.Effect of niclosamide on basal-like breast cancers.Genomic regulation of invasion by STAT3 in triple negative breast cancer.
P50
Q28076798-06DFBEFA-B62E-4E5B-8A38-25C109704B19Q30276749-E0850C09-EAF7-4AB0-93E2-B5E160BE49FAQ30820424-9EE3AA7A-BAE5-43B1-995F-2CE4CCCD7DA9Q31931758-515D765E-8D7C-4E19-B05C-F958346DBA8AQ33186427-6F8A3B8D-FA08-4054-A436-238479D99878Q33775762-73E53289-299C-406A-A5DC-4B6FBC15CB70Q33858203-A64C8D67-453B-478A-A5B6-93558B291C75Q33989940-ECC2C1D5-90B2-4143-8FDD-1E4D456A08BCQ34026273-B155FD7C-B171-4CBA-8334-39F9431743ECQ34066039-57C88914-3D82-494F-9FFD-08E73D7FFFA0Q34199032-B030DF6D-5617-4D25-B848-28BBF95DBFFAQ34504817-39AEE003-A8CC-4695-A736-0B15DD9F8AB3Q34610496-C5EFC98E-1F0F-4C10-AC7B-556047983DE8Q34612838-0ECCC119-FA92-444D-AAE9-A27CCC1E970BQ34912378-FAD4D438-ED19-4842-ABB2-A16E9129C5EEQ35079996-F5138F29-0292-4B42-BE67-B5893F5901BCQ35087006-F3A09F38-6B07-4C5F-A8ED-217FD06E79C5Q35095013-40D36AA6-C236-4C35-83EF-808F2535658BQ35790118-59881CB7-51FF-48D2-9954-6E00A44D7C7FQ35842473-51AEBA18-32C7-446C-B13B-B81B3578928AQ35883797-F59B879E-F487-4328-B2FD-20504580E562Q35970722-481BC5B2-729E-44F1-8F73-D2FB485462B7Q36174910-9C73238F-266F-45A9-9D42-2273646AA7D8Q36211616-3B7C6D3E-0B19-4935-81FD-CE869DDCAE92Q36572530-0D2290FE-F0BE-4315-AD40-2E97D4467CE9Q36865726-95C05B7A-9034-4E44-9AA4-3283EBD43698Q36917864-B137AC0D-1820-4D0C-9141-7E4BA38FC722Q36944419-1EEA11B2-1AE4-4D80-BFB8-72ED3F0AE50DQ37066527-9AE74B86-EE19-482C-A064-E0C664C180CFQ37117116-752F1906-D25C-4C9C-8FE4-922198F24DCDQ37238120-A07997AF-2DBE-49DF-9E79-B89413C5AEBBQ37254021-1A63FA0D-EBAE-4740-80B7-DD597EC7F4F5Q37268282-E2FB0181-4755-480C-8219-DECA98A6ADC3Q37355568-9D1198B3-07A8-453C-B7B8-BB7B520FC1EBQ37372980-0A997357-02FC-4246-9FC7-0CAAA4414B61Q37397924-E662EB30-92A9-4138-B5B1-86914A2BDE30Q37402833-3F0F79B0-9B06-43D6-8DBA-153268ED3A36Q37484367-4BA8B28A-2805-49C1-8287-1C304CA5708DQ37695022-101805F3-5EBB-4365-AB70-5455A1873F4CQ37702690-93F3B939-1ECC-4491-825C-F87256B26352
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Donald J Buchsbaum
@ast
Donald J Buchsbaum
@en
Donald J Buchsbaum
@es
Donald J Buchsbaum
@nl
type
label
Donald J Buchsbaum
@ast
Donald J Buchsbaum
@en
Donald J Buchsbaum
@es
Donald J Buchsbaum
@nl
prefLabel
Donald J Buchsbaum
@ast
Donald J Buchsbaum
@en
Donald J Buchsbaum
@es
Donald J Buchsbaum
@nl
P1153
24456082400
P31
P496
0000-0003-2797-5847